Recursion Pharmaceuticals stock jumps after securing full rights to REV102, aiming to fast-track the first oral therapy for hypophosphatasia.

Detailed price information for Rallybio Corporaton (RLYB-Q) from The Globe and Mail including charting and trades.

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

Former Google CEO Eric Schmidt warns that Artificial Superintelligence (ASI), surpassing human intelligence, is imminent. He ...